|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows used in operating activities | ||||
| Net loss for the year | ||||
| Items not affecting cash: | ||||
| Current income tax expense | ||||
| Depreciation | ||||
| Interest and finance income | ||||
| Realized gain on marketable securities | ||||
| Share-based compensation | ||||
| Unrealized fair value (gain) loss on marketable securities | ||||
| Unrealized foreign exchange loss (gain) | ||||
| Write-off of E&E assets | ||||
| Changes in non-cash working capital items: | ||||
| Receivables and other | ||||
| Accounts payable and accrued liabilities | ||||
| Income taxes paid | ||||
| Net cash used in operating activities | ||||
| Cash flows generated by investing activities | ||||
| Expenditures on E&E assets | ||||
| Interest received | ||||
| Proceeds from sale of marketable securities | ||||
| Purchase of property and equipment | ||||
| Purchase of short-term investments | ||||
| Redemption of short-term investments | ||||
| Net cash generated by investing activities | ||||
| Cash flows generated by financing activities | ||||
| Proceeds from exercise of share options | ||||
| Share issuance costs | ||||
| Net cash generated by financing activities | ||||
| Increase (decrease) in cash and cash equivalents for the year | ||||
| Cash and cash equivalents, beginning of year | ||||
| Effect of foreign exchange rate changes on cash and cash equivalents | ||||
| Cash and cash equivalents, end of year |
Loading...
